RVMD - Revolution Medicines, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$159.00
DETAILS
HIGH:
$205.00
LOW:
$73.00
MEDIAN:
$163.50
CONSENSUS:
$159.00
UPSIDE:
4.91%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 7.14 |
| Quick Ratio | 7.14 |
| Solvency Ratio | -1.541 |
| Cash Ratio | 1.32 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-13.39
Peers avg: 18.6
|
| PEG Ratio | -0.20 |
| Forward PEG | -0.20 |
| Price/Book | 9.28 |
| Price/Sales | 0.00 |
| Price/FCF | -16.57 |
| Price/Op Cash Flow | -16.87 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0674 |
| Debt/Equity | 0.0973 |
| Debt/Capital | 0.0887 |
| Long-Term Debt/Capital | 0.0802 |
| Financial Leverage | 1.44 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -3.091 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 101.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -26.79 |
| Interest Coverage | -48.7957 |
| Short-Term Operating Cash Flow Coverage | -54.51 |
| Operating Cash Flow Coverage | -5.66 |
| Capital Expenditure Coverage | -56.14 |
| Dividend + Capital Expenditure Coverage | -56.14 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -5.950 |
| Debt/Share | 0.9622 |
| Cash/Share | 10.65 |
| Book Value/Share | 8.58 |
| Tangible BV/Share | 8.21 |
| Equity/Share | 8.58 |
| Operating Cash Flow/Share | -4.722 |
| Capital Expenditure/Share | 0.084 |
| FCF/Share | -4.806 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.957 |
| Price/Fair Value | 9.28 |
| Debt/Market Cap | 0.0105 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -13.68 |